hotspot -WSS

hotspot

author：explore 2025-08-28 13:07:35 - browse：77762

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Why did Pfizer dish out millions for a Super Bowl ad?

WSS

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Doctors' information doesn't help them choose wisely when sick

Medicare threatens to cut off funding for HCA's Mission hospital

Biden report: The neurospychology of memory and aging

Why did Pfizer dish out millions for a Super Bowl ad?

A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.

focus

hotspot

entertainment

ChatGPT in medicine: STAT answers readers' burning questions

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

DIEP, the 'gold standard' of breast reconstruction, is under threat

New study raises questions about niacin and heart health

DIEP, the 'gold standard' of breast reconstruction, is under threat

What we’ve learned from the Aduhelm mess

The high cost of giving birth even with insurance

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Guidelines to prevent youth baseball injuries need more muscle

FDA warns medical device makers about rise in fabricated data

focus

MD Anderson's Padmanee Sharma responds to research credit suit

Hospitals are piloting generative AI tools as regulators play catch

WATCH: Why do our ears pop?

To avoid data mishandling cases, universities eye AI and other tools

WATCH: Why do our ears pop?

PhRMA lawsuit over Medicare drug price negotiation tossed

focus

hotspot

focus

knowledge